Yield10 Bioscience Appoints Agriculture Industry Veteran Sherri M. Brown, Ph.D., to Board of Directors
February 13 2020 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN today announced that Sherri
M. Brown, Ph.D. was appointed to the Company’s Board of Directors
effective February 11, 2020. In connection with her
appointment, Dr. Brown will serve as chair of a newly formed
Science and Technology Committee of the Board. Dr. Brown previously
served as a Special Commercial and Technical Advisor to the
Company.
“We are delighted that Sherri is expanding her role with Yield10
by serving on our Board of Directors,” said Oliver Peoples, Ph.D.,
president and chief executive officer of Yield10. “Her extensive
experience in the agriculture industry including her deep knowledge
in plant science, the assessment of yield traits in the field,
global business management experience, and knowledge of the
commercial landscape will continue to provide our team with
invaluable strategic insights and guidance as we build
Yield10.”
“Since joining Yield10 as a Commercial and Technical Advisor, I
have witnessed significant progression of the Company’s GRAIN
technology platform, an exciting new approach for identifying gene
targets for novel crop traits,” said Dr. Brown. “The Company is
using its Camelina platform to determine field performance for its
novel yield traits as a basis for establishing collaborations with
leading seed companies to evaluate these traits in major crops. In
addition, Yield10 has developed traits to improve the value of
Camelina as a crop for producing high value oils for food and feed,
and low cost PHA biomaterials for industrial markets. I am excited
about the Camelina system and its potential to provide additional
opportunities and revenue sources for farmers and I look forward to
continuing to work with the Yield10 team and contributing to the
Company’s technical and commercial success.”
Since 2017, Dr. Brown has served as the managing director of The
Yield Lab, a global agrifood tech accelerator based in St. Louis.
She previously served in several leadership positions involving the
development and global commercialization of new biotechnology
traits for canola, soybean and corn at Monsanto Company for 28
years. She served as Vice President, Science Strategy at Monsanto
from 2014 to 2017 and as a member of the Monsanto Leadership
Council. Prior to that, she was Vice President, Global Commercial
Technology/Product Development from 2008 to 2014 where she was
responsible for evaluating and launching the seed and trait
pipeline, including eight new biotech traits. In addition, she was
Vice President, Technology, Global Corn Business (1999-2004) and
Vice President, Technology, Oilseeds Business team (1998-1999). Dr.
Brown earned a Ph.D. at Indiana University, Bloomington, IN with a
major in Genetics/Molecular, Cellular and Developmental Biology.
She earned a B.S. at Hope College, Holland, MI with a double major
in Biology and Chemistry.
The Company also announced today that Peter Kellogg has stepped
down from the Board of Directors, effective February 11,
2020. Further, the Company announced that Board member
Anthony Sinskey, Ph.D. has been appointed to serve as a member of
the Audit Committee of the Board, effective February 11,
2020.
Dr. Peoples commented, “On behalf of the Board and management
team, we thank Peter for his support, leadership, valuable insights
and many contributions over the past thirteen years and wish him
every success in the future.”
Mr. Kellogg recently retired as executive vice president and
chief corporate strategy officer of Celgene Corporation in
conjunction with the acquisition of the company by Bristol-Myers
Squibb in 2019.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
which uses its “Trait Factory” to develop high value seed traits
for the agriculture and food industries to achieve step-change
improvements in crop yield to enhance global food security and
develop specialty crop products. Yield10 has an extensive track
record of innovation based around optimizing the flow of carbon in
living systems. The “Trait Factory” has two components: the “GRAIN”
computational modeling platform, which is used to identify specific
gene changes designed to improve crop performance, and the
deployment of those changes into crops using genome-editing or
traditional agricultural biotechnology approaches. The purpose of
the “Trait Factory” is to engineer precise alterations to gene
activity and the flow of carbon in plants to produce higher yields
with lower inputs of land, water or fertilizer. Yield10 is
advancing several yield traits it has developed in crops such as
canola, soybean, and corn. Yield10 is headquartered in Woburn, MA
and has an Oilseeds Center of Excellence in Saskatoon,
Canada.
For more information about the company, please visit
www.yield10bio.com.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, expectations regarding the progress of Yield10
Bioscience, Inc., constitute forward-looking statements. Such
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results to differ materially
from those anticipated, including the risks and uncertainties
detailed in Yield10 Bioscience's filings with the Securities and
Exchange Commission. Yield10 assumes no obligation to update any
forward-looking information contained in this press release or with
respect to the matters described herein.
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, 561-479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
Marketing and PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024